Detalhe da pesquisa
1.
Improvement of genomic prediction in advanced wheat breeding lines by including additive-by-additive epistasis.
Theor Appl Genet
; 135(3): 965-978, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34973112
2.
Sustained virological response to direct-acting antiviral regimens reduces the risk of hepatocellular carcinoma in HIV/HCV-coinfected patients with cirrhosis.
J Antimicrob Chemother
; 73(9): 2435-2443, 2018 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29982683
3.
Changes in Liver Steatosis After Switching From Efavirenz to Raltegravir Among Human Immunodeficiency Virus-Infected Patients With Nonalcoholic Fatty Liver Disease.
Clin Infect Dis
; 65(6): 1012-1019, 2017 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28903510
4.
Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus-coinfected patients with mild fibrosis in the short term.
Hepatology
; 61(5): 1503-11, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25545020
5.
Genomic prediction for root and yield traits of barley under a water availability gradient: a case study comparing different spatial adjustments.
Plant Methods
; 20(1): 8, 2024 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38216953
6.
Integrating a growth degree-days based reaction norm methodology and multi-trait modeling for genomic prediction in wheat.
Front Plant Sci
; 13: 939448, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36119585
7.
Genomic prediction for grain yield and micro-environmental sensitivity in winter wheat.
Front Plant Sci
; 13: 1075077, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36816478
8.
Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/hepatitis C virus-coinfected patients.
AIDS
; 32(11): 1423-1430, 2018 07 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29596108
9.
Liver stiffness predicts variceal bleeding in HIV/HCV-coinfected patients with compensated cirrhosis.
AIDS
; 31(4): 493-500, 2017 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27922855
10.
Correction: Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study.
PLoS One
; 12(2): e0172184, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28182783
11.
Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study.
PLoS One
; 11(10): e0164455, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27727331